首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1485301

獸醫眼保健市場規模 - 按產品和服務、動物類型、適應症、最終用途和預測，2024 年 - 2032 年

Veterinary Eye Care Market Size - By Product & Services, Animal Type, Indication, End-use & Forecast, 2024 - 2032

出版日期: 2024年03月14日 | 出版商:

Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

隨著獸醫眼科的進步和專業眼部護理產品的推出，受寵物眼部疾病高發生率的推動，2024 年至 2032 年全球獸醫眼部護理市場的複合年成長率將達到 3.5%。由於寵物面臨白內障、青光眼和感染等常見疾病，對有效治療的需求非常大。此外，現代診斷工具和創新療法的發展提高了護理品質。這為獸醫眼保健行業的擴張創造了一個充滿希望的前景，滿足寵物主人為寵物尋求最佳眼睛健康日益成長的需求。

例如，2024 年 1 月，ENTOD Pharmaceuticals 推出了“FUR”，這是一個為寵物提供眼部和耳部護理藥物的部門。 FUR 提供多種獸醫解決方案，包括潤滑滴劑、抗青光眼藥物、抗過敏藥物、抗生素及其組合。它反映了人們對寵物保健產品的認知和需求不斷成長，表明人們越來越關注解決寵物的特定眼睛和聽覺狀況。這項發展可以透過提供創新的治療方法並在更廣泛的範圍內提高獸醫眼部和耳部護理選擇的可用性來促進市場成長。

獸醫眼保健市場根據產品和服務、動物類型、適應症、最終用途和地區而分散。

由於人們越來越重視貓科動物的健康，特別是它們脆弱的眼睛需求，貓科動物市場將在 2024 年至 2032 年顯著擴張。世界各地的貓主人越來越重視全面的眼部護理，從預防措施到先進的治療。隨著貓成為全球流行的寵物，這個細分市場的重要性可能會穩定成長。隨著主人與其貓科動物夥伴之間的聯繫加強，人們對保持最佳眼睛健康重要性的認知也隨之增強，從而使貓科動物成為獸醫眼保健行業的關鍵驅動力。

由於對寵物各種眼部疾病準確、及時診斷的需求不斷成長，診斷實驗室領域將在 2032 年呈現健康的成長速度。這些專業實驗室提供先進的診斷工具和專業知識，幫助獸醫精確定位眼部疾病。隨著寵物主人對寵物健康的關注度越來越高，對診斷實驗室進行徹底眼部檢查的依賴也越來越大。診斷實驗室在識別和管理眼睛問題方面發揮著至關重要的作用，因此將成為寵物護理行業成長的關鍵組成部分。

2024年至2032年，亞太地區獸醫眼保健市場規模將出現大幅複合年成長率。此外，該地區可支配收入的增加使得寵物醫療保健方面的支出增加。獸醫眼科的技術進步也在增強診斷和治療選擇方面發揮了作用。隨著越來越多的寵物主人尋求高品質的眼部治療，亞太地區將成為全球獸醫眼部護理行業成長的顯著貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 寵物眼部疾病的發生率上升
  - 增加獸醫醫療保健支出
  - 全球寵物擁有量增加
  - 獸醫眼科的進展
- 產業陷阱與挑戰
  - 治療費用高
  - 缺乏保險保障
成長潛力分析
監管環境
波特的分析
PESTEL分析
定價分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀錶板

第 5 章：市場估計與預測：按產品和服務分類，2018 年 - 2032 年

主要趨勢
獸醫護理產品
- 診斷
  - 眼壓計
  - 眼科測試套件
  - 視網膜電圖（ERG）
  - 眼底相機
  - 檢眼鏡
  - 測厚儀
  - 其他診斷產品
- 治療
  - 藥品
    - 藥品類型
    - 抗生素
    - 非類固醇抗發炎藥
    - 皮質類固醇
    - 其他藥品
    - 依給藥途徑
    - 口服
    - 專題
    - 可注射
    - 按配銷通路
    - 獸醫醫院藥房
    - 零售藥局
    - 寵物專賣店
    - 電子商務
  - 鏡片
    - 繃帶鏡片
    - 人工水晶體
  - 雷射設備
獸醫護理服務

第 6 章：市場估計與預測：按動物類型，2018 - 2032

主要趨勢
犬類
貓科動物
馬科
牛科
其他動物類型

第 7 章：市場估計與預測：按指標分類，2018 年 - 2032 年

主要趨勢
眼瞼異常
白內障
青光眼
視網膜疾病
葡萄膜炎
結膜炎
角膜潰瘍
其他適應症

第 8 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
獸醫院
診斷實驗室
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 10 章：公司簡介

An-Vision GmbH
Bausch & Lomb Inc.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
IRIDEX Corporation
I-Med Animal Health
LKC Technologies, Inc.
Neuronix Ltd.
OptoMed
Reichert, Inc.
Zoetis Services LLC

簡介目錄

Product Code: 8499

Global Veterinary Eye Care Market will register 3.5% CAGR between 2024 and 2032, driven by the high incidence of eye conditions in pets, in line with advancements in veterinary ophthalmology and the introduction of specialized eye care products. With pets facing common ailments like cataracts, glaucoma, and infections, the demand for effective treatments is significant. Furthermore, the development of modern diagnostic tools and innovative treatments enhances the quality of care. This creates a promising landscape for the expansion of the veterinary eye care industry, catering to the increasing needs of pet owners seeking optimal eye health for their companions.

For instance, in January 2024, ENTOD Pharmaceuticals introduced 'FUR,' a division offering eye and ear care medicines for pets. FUR provides a diverse range of veterinary solutions, including lubricating drops, anti-glaucoma medications, anti-allergies, antibiotics, and combinations. It reflects the growing awareness and demand for pet health products, suggesting an increasing focus on addressing specific ocular and aural conditions in pets. This development could contribute to the market growth by offering innovative treatments and enhancing the availability of veterinary eye and ear care options on a broader scale.

The veterinary eye care market is fragmented based on products and services, animal type, indication, end-use, and region.

The feline segment will witness a notable expansion over 2024-2032, fueled by a growing emphasis on feline health, particularly their delicate ocular needs. Cat owners worldwide are increasingly prioritizing comprehensive eye care, from preventive measures to advanced treatments. With cats being popular pets globally, this segment's prominence could grow steadily. As the bond between owners and their feline companions strengthens, so does the recognition of the importance of maintaining optimal eye health, making the feline segment a key driver in the veterinary eye care industry.

The diagnostic laboratories segment will exhibit a healthy growth rate through 2032, propelled by the increasing demand for accurate and timely diagnoses of various eye conditions in pets. These specialized laboratories offer advanced diagnostic tools and expertise, aiding veterinarians in pinpointing ocular diseases with precision. As pet owners become more proactive about their pets' health, the reliance on diagnostic laboratories for thorough eye examinations grows. With their crucial role in identifying and managing eye issues, the diagnostic laboratories segment will emerge as a pivotal component of the pet care industry's growth.

Asia Pacific veterinary eye care market size will experience a substantial CAGR from 2024 to 2032. Rapid urbanization, increasing pet adoption rates, and a growing awareness of animal health drive this trend. Moreover, the region's rising disposable incomes allow for greater spending on pet healthcare. Technological advancements in veterinary ophthalmology also play a role in enhancing diagnosis and treatment options. With an increasing number of pet owners seeking high-quality eye treatments, the Asia Pacific region will stand as a remarkable contributor to the global veterinary eye care industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of eye disorders in pets
  - 3.2.1.2 Increasing veterinary healthcare expenditure
  - 3.2.1.3 Increasing pet ownership globally
  - 3.2.1.4 Advancements in veterinary ophthalmology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of treatment
  - 3.2.2.2 Lack of insurance coverage
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis
3.7 Pricing analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product & Services, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Veterinary care products
- 5.2.1 Diagnosis
  - 5.2.1.1 Tonometer
  - 5.2.1.2 Ophthalmic test kits
  - 5.2.1.3 Electroretinogram (ERG)
  - 5.2.1.4 Fundus camera
  - 5.2.1.5 Ophthalmoscope
  - 5.2.1.6 Pachymeter
  - 5.2.1.7 Other diagnostic products
- 5.2.2 Treatment
  - 5.2.2.1 Drugs
    - 5.2.2.1.1 Drug type
    - 5.2.2.1.1.1 Antibiotics
    - 5.2.2.1.1.2 NSAIDs
    - 5.2.2.1.1.3 Corticosteroids
    - 5.2.2.1.1.4 Other drugs
    - 5.2.2.1.2 By route of administration
    - 5.2.2.1.2.1 Oral
    - 5.2.2.1.2.2 Topical
    - 5.2.2.1.2.3 Injectable
    - 5.2.2.1.3 By distribution channel
    - 5.2.2.1.3.1 Veterinary hospitals pharmacies
    - 5.2.2.1.3.2 Retail drug stores
    - 5.2.2.1.3.3 Pet specialty stores
    - 5.2.2.1.3.4 E-commerce
  - 5.2.2.2 Lenses
    - 5.2.2.2.1 Bandage lenses
    - 5.2.2.2.2 Intraocular lenses
  - 5.2.2.3 Laser devices
5.3 Veterinary care services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Canine
6.3 Feline
6.4 Equine
6.5 Bovine
6.6 Other animal type

Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Eyelid abnormalities
7.3 Cataract
7.4 Glaucoma
7.5 Retinal disorders
7.6 Uveitis
7.7 Conjunctivitis
7.8 Corneal ulcers
7.9 Other indications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Veterinary hospitals
8.3 Diagnostic laboratories
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa